Vytisknout
0571503 - BC 2024 RIV GB eng J - Článek v odborném periodiku
Mulgaonkar, N. - Wang, H. - Mallawarachchi, S. - Růžek, Daniel - Martina, B. - Fernando, S.
In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2.
Journal of Biomolecular Structure & Dynamics. Roč. 41, č. 7 (2023), s. 3052-3061. ISSN 0739-1102
Grant CEP: GA MZd(CZ) NU20-05-00472
Institucionální podpora: RVO:60077344
Klíčová slova: SARS-CoV-2 * covid-19 * betacoronavirus * acute respiratory disease * Wuhan * ace2 * surface structural spike glycoprotein * molecular docking * Bcr-Abl tyrosine kinase inhibitor * imatinib
Obor OECD: Microbiology
Impakt faktor: 4.4, rok: 2022
Způsob publikování: Open access
https://www.tandfonline.com/doi/abs/10.1080/07391102.2022.2045221?journalCode=tbsd20
Trvalý link: https://hdl.handle.net/11104/0343719
Mulgaonkar, N. - Wang, H. - Mallawarachchi, S. - Růžek, Daniel - Martina, B. - Fernando, S.
In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2.
Journal of Biomolecular Structure & Dynamics. Roč. 41, č. 7 (2023), s. 3052-3061. ISSN 0739-1102
Grant CEP: GA MZd(CZ) NU20-05-00472
Institucionální podpora: RVO:60077344
Klíčová slova: SARS-CoV-2 * covid-19 * betacoronavirus * acute respiratory disease * Wuhan * ace2 * surface structural spike glycoprotein * molecular docking * Bcr-Abl tyrosine kinase inhibitor * imatinib
Obor OECD: Microbiology
Impakt faktor: 4.4, rok: 2022
Způsob publikování: Open access
https://www.tandfonline.com/doi/abs/10.1080/07391102.2022.2045221?journalCode=tbsd20
Trvalý link: https://hdl.handle.net/11104/0343719